Mild depression affects HCV treatment success, study says

09/9/2011 | Medscape (free registration)

Mildly depressed patients with hepatitis C virus who begin interferon-based antiviral therapy could see their depression symptoms worsen, which may make it more likely they will discontinue treatment, researchers reported in the American Journal of Gastroenterology. The study team from the Veterans Affairs Palo Alto Health Care System and Stanford University also found that 53% of minimally depressed patients did not achieve a sustained virologic response to treatment, compared with those who were mildly or moderately depressed. Read the abstract.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC